Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Arizona, VET CBD's performance in the Edible category has been relatively stable, though not within the top 30 brands, as evidenced by its rankings of 48th and 47th in January and February 2025, respectively. This indicates a consistent presence but also highlights room for improvement to break into the top 30. In contrast, the Tincture & Sublingual category in Arizona shows a promising development, as VET CBD achieved a notable 4th place in April 2025, suggesting strong performance and potential market leadership in this segment. This contrast between categories within the same state provides an interesting perspective on the brand's strategic positioning and consumer preferences.
In California, VET CBD has maintained a solid position in the Tincture & Sublingual category, consistently ranking 4th throughout the first four months of 2025. This stability is complemented by a noticeable increase in sales from February to March, indicating growing consumer demand and potential market expansion. The consistent ranking in California, a significant market, underscores VET CBD's strong brand recognition and product appeal in this category. This performance could be indicative of a broader trend or strategy that could be replicated in other states to enhance their market presence.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, VET CBD consistently held the 4th rank from January to April 2025, demonstrating a stable market presence. Despite this consistency, VET CBD faces stiff competition from brands like Yummi Karma, which improved its rank from 3rd to 2nd place by April 2025, indicating a strong upward trend in sales. Meanwhile, Care By Design experienced fluctuations, dropping from 1st to 3rd place, which might suggest opportunities for VET CBD to capitalize on any potential gaps left by Care By Design's shifting market position. Additionally, Mary's Medicinals and Friendly Farms maintained lower ranks, with Mary's Medicinals consistently at 5th place, suggesting that while they are competitors, they pose less of a threat to VET CBD's current standing. This competitive analysis highlights the importance for VET CBD to strategize effectively to maintain its rank and potentially improve its market share amidst dynamic shifts among its competitors.
Notable Products
In April 2025, VET CBD's top-performing product was the CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) in the Tincture & Sublingual category, maintaining its position from March with sales of 1174 units. The CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) ranked second, slipping from its previous top spot in January and March. The CBD/THC 10:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz) consistently held the third position for four consecutive months. The CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) improved its ranking from fifth in January to fourth in April. Lastly, the CBD/THC 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz) dropped to fifth, reflecting a slight decline in sales figures over the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.